You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 243 No. 4, January 25, 1980 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Opiate Withdrawal Using Clonidine

A Safe, Effective, and Rapid Nonopiate Treatment

Mark S. Gold, MD; A. Carter Pottash, MD; Donald R. Sweeney, MD, PhD; Herbert D. Kleber, MD

JAMA. 1980;243(4):343-346.


Abstract

Clonidine hydrochloride was administered to ten patients in an inpatient setting after abrupt discontinuation of chronic methadone hydrochloride administration. Clonidine produced a rapid and statistically significant decrease in opiate withdrawal signs and symptoms. Clonidine administration for 14 days enabled all patients to be successfully detoxified from chronic opiate administration. In all patients studied, clonidine was a safe and effective nonopiate treatment of opiate withdrawal that suppressed the affect, signs, and symptoms of opiate withdrawal. These data support the hypothesis that the {alpha}2-adrenergic agonist, clonidine, has substantial antiwithdrawal effect by replacing opiate-mediated inhibition with {alpha}2-mediated inhibition of brain noradrenergic activity.

(JAMA 243:343-346, 1980)



Author Affiliations

From the Department of Psychiatry (Drs Gold, Pottash, and Sweeney) and Substance Abuse Unit (Dr Kleber), Yale University School of Medicine, New Haven, Conn; and Research Facilities, Fair Oaks Hospital (Drs Gold, Pottash, and Sweeney), Summit, NJ.


Footnotes

Reprint requests to Research Facilities, Fair Oaks Hospital, 19 Prospect St, Summit, NJ 07901 (Dr Gold).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Clonidine as an Adjunct Therapy to Opioids for Neonatal Abstinence Syndrome: A Randomized, Controlled Trial
Agthe et al.
Pediatrics 2009;123:e849-e856.
ABSTRACT | FULL TEXT  

Intrathecal and Oral Clonidine as Prophylaxis for Postoperative Alcohol Withdrawal Syndrome: A Randomized Double-Blinded Study
Dobrydnjov et al.
Anesth. Analg. 2004;98:738-744.
ABSTRACT | FULL TEXT  

The Effect of Clonidine on Gastrointestinal Side Effects Associated with Ultra-Rapid Opioid Detoxification
Ma et al.
Anesth. Analg. 2003;96:1409-1412.
ABSTRACT | FULL TEXT  

Nor-binaltorphimine Precipitates Withdrawal and Excitatory Amino Acid Release in the Locus Ceruleus of Butorphanol---but Not Morphine-Dependent Rats
Feng et al.
J. Pharmacol. Exp. Ther. 1997;283:932-938.
ABSTRACT | FULL TEXT  

Transport of Clonidine Across Cultured Brain Microvessel Endothelial Cells
Huwyler et al.
J. Pharmacol. Exp. Ther. 1997;282:81-85.
ABSTRACT | FULL TEXT  

Effects of Transdermal Clonidine Treatment on Withdrawal Symptoms Associated With Smoking Cessation: A Randomized, Controlled Trial
Ornish et al.
Arch Intern Med 1988;148:2027-2031.
ABSTRACT  

Clonidine vs Chlordiazepoxide in the Management of Acute Alcohol Withdrawal Syndrome
Baumgartner and Rowen
Arch Intern Med 1987;147:1223-1226.
ABSTRACT  

Narcotic Withdrawal Syndrome in Young Adults After the Therapeutic Use of Opiates
Miser et al.
Arch Pediatr Adolesc Med 1986;140:603-604.
ABSTRACT  

Evaluation and Treatment of Agitation in the Intensive Care Unit
Tesar and Stern
J Intensive Care Med 1986;1:137-148.
ABSTRACT  

Clonidine in Morphine Withdrawal: Differential Effects on Signs and Symptoms
Jasinski et al.
Arch Gen Psychiatry 1985;42:1063-1066.
ABSTRACT  

Clonidine in Outpatient Detoxification From Methadone Maintenance
Kleber et al.
Arch Gen Psychiatry 1985;42:391-394.
ABSTRACT  

Narcotic Bowel Syndrome Treated with Clonidine: Resolution of Abdominal Pain and Intestinal Pseudo-Obstruction
SANDGREN et al.
ANN INTERN MED 1984;101:331-334.
ABSTRACT  

Failure of Naloxone to Reverse Clonidine Toxic Effect
Banner et al.
Arch Pediatr Adolesc Med 1983;137:1170-1171.
ABSTRACT  

Propoxyphene in Children With Iatrogenic Morphine Dependence: A Review of the Literature With Two Additional Cases
Hasday and Weintraub
Arch Pediatr Adolesc Med 1983;137:745-748.
ABSTRACT  

Efficacy of Naloxone in Clonidine Poisoning
NORTH and PETERSON
Arch Pediatr Adolesc Med 1983;137:807-808.
ABSTRACT  

Clonidine and Naltrexone: A Safe, Effective, and Rapid Treatment of Abrupt Withdrawal From Methadone Therapy
Charney et al.
Arch Gen Psychiatry 1982;39:1327-1332.
ABSTRACT  

Outpatient Treatment of Prescription Opioid Dependence: Comparison of Two Methods
Tennant and Rawson
Arch Intern Med 1982;142:1845-1847.
ABSTRACT  

The Clinical Use of Clonidine in Abrupt Withdrawal From Methadone: Effects on Blood Prennssure and Specific Signs and Symptoms
Charney et al.
Arch Gen Psychiatry 1981;38:1273-1277.
ABSTRACT  

Clonidine Ameliorates Gilles de la Tourette Syndrome
Cohen et al.
Arch Gen Psychiatry 1980;37:1350-1357.
ABSTRACT  

Internal Medicine
Gray and Soffer
JAMA 1980;243:2190-2191.
ABSTRACT  

Psychiatry
Freedman
JAMA 1980;243:2208-2210.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1980 American Medical Association. All Rights Reserved.